Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare ...
Obesity Care Week (OCW) returns for its annual global campaign aimed at raising awareness, educating and advocating for individuals affected by obesity. This year's theme, "Commit to Care," emphasizes ...
Health insurance companies are lobbying against proposals that would expand prescription access to weight-loss medications.
New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...
The Department of Social Services remains committed to exploring policy solutions that maximize health outcomes while maintaining fiscal sustainability ...
Republicans trying to find billions of Medicaid dollars to pay for tax cuts now say that any reduction in Medicaid spending ...
11h
News Medical on MSNStudy shows benefits of GLP-1 drugs for kidney transplant recipients with type 2 diabetesKidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.
Pharmaceutical manufacturer Novo Nordisk on Wednesday announced it will be offering a direct-to-patient program for uninsured ...
We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results